News
Factor XI inhibitor–based anticoagulation strategies gain ground
November 18, 2020
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
News
COVID-19: Thromboembolic events high despite prophylaxis
October 27, 2020
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”
![1]()
Article
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate
October 20, 2020
Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival, comparable with the general population.
News
Blood group O linked to decreased risk of SARS-CoV-2 infection
October 15, 2020
A retrospective analysis of all Danish individuals with a known ABO blood group tested for SARS-CoV-2 showed a lower infection risk for SARS-CoV-2 infection in blood group O.
![1]()
News
INR fails to predict bleeding in patients with cirrhosis
October 6, 2020
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.
![1]()
News
No rise in major hemorrhagic events with antiplatelet therapy after ICH
August 3, 2020
Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming antiplatelet therapy following an ICH?
![1]()
Opinion
Hematologic manifestations of COVID-19
July 29, 2020
Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effects.
![1]()
Article
Endothelial injury may play a major role in COVID-19–associated coagulopathy
June 29, 2020
Dr. Alan P. Lyss reviews research suggesting endotheliopathy may be a marker of COVID-19 severity.
News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
May 26, 2020
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available very rapidly.”
![1]()
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
May 26, 2020
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
